SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-May-24 5:13 PM View: | Piedmont Office Realty Trus... (N/A) | 07-May-24 | Payment of Exercise | 4,413 | $6.95 | $30,670.30 | (22%) 20.45K to 16.04K | |
08-May-24 5:13 PM View: | Piedmont Office Realty Trus... (N/A) | 07-May-24 | Option Exercise | 15,220 | -- | -- | 291% 5.23K to 20.45K | |
12-May-23 4:37 PM View: | Piedmont Office Realty Trus... (N/A) | 10-May-23 | Payment of Exercise | 2,135 | $6.57 | $14,027.00 | (29%) 7.36K to 5.23K | |
12-May-23 4:37 PM View: | Piedmont Office Realty Trus... (N/A) | 10-May-23 | Option Exercise | 7,363 | -- | -- | 100% 0 to 7.36K | |
03-Mar-20 6:26 PM View: | Cyrusone Inc. (CONE) | 28-Feb-20 | Payment of Exercise | 6,520 | $60.58 | $394,982.00 | (5%) 121.3K to 114.78K | (18%) |
27-Feb-20 6:05 PM View: | Cyrusone Inc. (CONE) | 26-Feb-20 | Payment of Exercise | 612 | $66.28 | $40,563.40 | (< 1%) 121.91K to 121.3K | (7%) |
25-Feb-20 6:52 PM View: | Cyrusone Inc. (CONE) | 21-Feb-20 | Payment of Exercise | 822 | $69.60 | $57,211.20 | (< 1%) 122.73K to 121.91K | (2%) |
18-Feb-20 5:00 PM View: | Cyrusone Inc. (CONE) | 17-Feb-20 | Grant | 18,699 | -- | -- | 18% 104.03K to 122.73K | |
18-Feb-20 5:00 PM View: | Cyrusone Inc. (CONE) | 13-Feb-20 | Payment of Exercise | 545 | $66.79 | $36,400.60 | (< 1%) 104.58K to 104.03K | (7%) |
06-Nov-19 5:11 PM View: | Cyrusone Inc. (CONE) | 04-Nov-19 | Market Sale | 29,911 | $70.48 | $2,108,230.00 | (15%) 195.69K to 165.78K | (< 1%) |
04-Mar-19 5:02 PM View: | Cyrusone Inc. (CONE) | 28-Feb-19 | Payment of Exercise | 1,466 | $49.84 | $73,065.40 | (< 1%) 201.81K to 200.34K | (41%) |
28-Feb-19 10:00 PM View: | Cyrusone Inc. (CONE) | 26-Feb-19 | Payment of Exercise | 612 | $50.48 | $30,893.80 | (< 1%) 202.42K to 201.81K | (39%) |
25-Feb-19 5:05 PM View: | Cyrusone Inc. (CONE) | 21-Feb-19 | Grant | 7,864 | -- | -- | 4% 194.56K to 202.42K | |
20-Feb-19 9:34 PM View: | Cyrusone Inc. (CONE) | 18-Feb-19 | Grant | 4,675 | -- | -- | 2% 196.79K to 201.47K | |
20-Feb-19 9:34 PM View: | Cyrusone Inc. (CONE) | 18-Feb-19 | Disposition | 6,909 | -- | -- | (3%) 201.47K to 194.56K | |
15-Feb-19 5:20 PM View: | Cyrusone Inc. (CONE) | 13-Feb-19 | Payment of Exercise | 489 | $54.95 | $26,870.60 | < 1% 303.9K to 304.39K | 28% |
05-Feb-19 5:51 PM View: | Cyrusone Inc. (CONE) | 01-Feb-19 | Payment of Exercise | 29,951 | $54.15 | $1,621,850.00 | (13%) 227.23K to 197.28K | (30%) |
08-Aug-18 6:20 PM View: | Cyrusone Inc. (CONE) | 06-Aug-18 | Market Sale | 5,000 | $64.96 | $324,780.00 | (2%) 232.71K to 227.71K | (8%) |
02-Mar-18 10:00 PM View: | Cyrusone Inc. (CONE) | 28-Feb-18 | Grant | 30,276 | -- | -- | 14% 218.47K to 248.74K | |
02-Mar-18 10:00 PM View: | Cyrusone Inc. (CONE) | 28-Feb-18 | Payment of Exercise | 11,030 | $49.90 | $550,397.00 | (4%) 248.74K to 237.71K | (39%) |
02-Mar-18 10:00 PM View: | Cyrusone Inc. (CONE) | 28-Feb-18 | Market Sale | 5,000 | $50.63 | $253,168.00 | (2%) 237.71K to 232.71K | (37%) |
28-Feb-18 6:04 PM View: | Cyrusone Inc. (CONE) | 26-Feb-18 | Grant | 5,847 | -- | -- | 3% 212.62K to 218.47K | |
05-Feb-19 5:51 PM View: | Cyrusone Inc. (CONE) | 13-Feb-18 | Payment of Exercise | 481 | $54.22 | $26,079.80 | (< 1%) 227.71K to 227.23K | (28%) |
13-Feb-18 6:16 PM View: | Cyrusone Inc. (CONE) | 10-Feb-18 | Payment of Exercise | 792 | $53.62 | $42,467.00 | (< 1%) 213.41K to 212.62K | (29%) |
05-Feb-18 5:32 PM View: | Cyrusone Inc. (CONE) | 01-Feb-18 | Payment of Exercise | 652 | $56.93 | $37,118.40 | (< 1%) 214.06K to 213.41K | (21%) |
06-Nov-17 5:30 PM View: | Cyrusone Inc. (CONE) | 02-Nov-17 | Market Sale | 13,500 | $60.20 | $812,727.00 | (6%) 227.56K to 214.06K | (14%) |
05-Apr-17 6:27 PM View: | Cyrusone Inc. (CONE) | 03-Apr-17 | Market Sale (Planned) | 11,779 | $50.90 | $599,608.00 | (5%) 239.34K to 227.56K | (33%) |
20-Mar-17 4:22 PM View: | Cyrusone Inc. (CONE) | 16-Mar-17 | Market Sale | 10,000 | $50.69 | $506,904.00 | (4%) 249.34K to 239.34K | (32%) |
02-Mar-17 6:10 PM View: | Cyrusone Inc. (CONE) | 28-Feb-17 | Payment of Exercise | 4,935 | $50.90 | $251,192.00 | (2%) 254.28K to 249.34K | (32%) |
15-Feb-17 6:55 PM View: | Cyrusone Inc. (CONE) | 13-Feb-17 | Grant | 4,674 | -- | -- | 2% 261.85K to 266.52K | |
15-Feb-17 6:55 PM View: | Cyrusone Inc. (CONE) | 13-Feb-17 | Payment of Exercise | 12,243 | $48.13 | $589,256.00 | (5%) 266.52K to 254.28K | (39%) |
14-Feb-17 10:00 PM View: | Cyrusone Inc. (CONE) | 10-Feb-17 | Payment of Exercise | 672 | $48.45 | $32,558.40 | (< 1%) 262.52K to 261.85K | (39%) |
03-Feb-17 4:19 PM View: | Cyrusone Inc. (CONE) | 01-Feb-17 | Payment of Exercise | 563 | $47.31 | $26,635.50 | (< 1%) 283.08K to 282.52K | (42%) |
03-Feb-17 4:19 PM View: | Cyrusone Inc. (CONE) | 01-Feb-17 | Market Sale (Planned) | 20,000 | $47.98 | $959,676.00 | (7%) 282.52K to 262.52K | (40%) |
19-Dec-16 5:23 PM View: | Cyrusone Inc. (CONE) | 15-Dec-16 | Market Sale (Planned) | 6,737 | $44.51 | $299,847.00 | (2%) 289.82K to 283.08K | (52%) |
04-Apr-16 5:02 PM View: | Cyrusone Inc. (CONE) | 31-Mar-16 | Payment of Exercise | 6,773 | $45.66 | $309,255.00 | (2%) 296.59K to 289.82K | (49%) |
01-Mar-16 4:33 PM View: | Cyrusone Inc. (CONE) | 28-Feb-16 | Payment of Exercise | 3,392 | $40.14 | $136,155.00 | (1%) 299.98K to 296.59K | (69%) |
11-Feb-16 5:52 PM View: | Cyrusone Inc. (CONE) | 10-Feb-16 | Payment of Exercise | 1,131 | $34.39 | $38,895.10 | (< 1%) 301.11K to 299.98K | (97%) |
09-Feb-16 4:53 PM View: | Cyrusone Inc. (CONE) | 07-Feb-16 | Payment of Exercise | 2,786 | $34.39 | $95,810.50 | (< 1%) 303.9K to 301.11K | (97%) |
03-Feb-16 5:13 PM View: | Cyrusone Inc. (CONE) | 01-Feb-16 | Grant | 105,171 | -- | -- | 53% 198.73K to 303.9K | |
26-Jan-16 4:15 PM View: | Cyrusone Inc. (CONE) | 24-Jan-16 | Payment of Exercise | 41,072 | $35.64 | $1,463,810.00 | (17%) 239.8K to 198.73K | (90%) |
02-Apr-15 2:45 PM View: | Cyrusone Inc. (CONE) | 31-Mar-15 | Payment of Exercise | 679 | $31.12 | $21,130.50 | (< 1%) 240.48K to 239.8K | (118%) |
12-Feb-15 6:37 PM View: | Cyrusone Inc. (CONE) | 10-Feb-15 | Grant | 48,491 | $28.42 | $1,378,110.00 | 25% 194.13K to 242.62K | 139% |
12-Feb-15 6:37 PM View: | Cyrusone Inc. (CONE) | 10-Feb-15 | Payment of Exercise | 2,143 | $28.42 | $60,904.10 | (< 1%) 242.62K to 240.48K | (139%) |
02-Apr-14 2:34 PM View: | Cyrusone Inc. (CONE) | 31-Mar-14 | Payment of Exercise | 628 | $20.83 | $13,081.20 | (< 1%) 194.76K to 194.13K | (226%) |
11-Feb-14 3:53 PM View: | Cyrusone Inc. (CONE) | 07-Feb-14 | Grant | 72,640 | -- | -- | 59% 122.12K to 194.76K | |
19-Apr-13 7:50 PM View: | Cyrusone Inc. (CONE) | 17-Apr-13 | Grant | 27,514 | -- | -- | 29% 94.61K to 122.12K | |
28-Jan-13 5:22 PM View: | Cyrusone Inc. (CONE) | 24-Jan-13 | Grant | 92,106 | -- | -- | 100% 0 to 92.11K | |
28-Jan-13 5:22 PM View: | Cyrusone Inc. (CONE) | 24-Jan-13 | Purchase | 2,500 | $19.00 | $47,500.00 | 3% 92.11K to 94.61K |